Terms: = Head and neck cancer AND NUP98, NUP196, 4928, ADIR2, ENSG00000110713
1 results:
1. Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach.
Even AJ; Hamming-Vrieze O; van Elmpt W; Winnepenninckx VJ; Heukelom J; Tesselaar ME; Vogel WV; Hoeben A; Zegers CM; Vugts DJ; van Dongen GA; Bartelink H; Mottaghy FM; Hoebers F; Lambin P
Oncotarget; 2017 Jan; 8(3):3870-3880. PubMed ID: 27965472
[TBL] [Abstract] [Full Text] [Related]